UK markets open in 2 hours 3 minutes
NIKKEI 225
38,032.00 +403.52 (+1.07%) HANG SENG
17,626.75 +342.21 (+1.98%) CRUDE OIL
83.87 +0.30 (+0.36%) GOLD FUTURES
2,347.80 +5.30 (+0.23%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,421.04 -20.72 (-0.04%)
Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 67.08 |
| Open | 67.45 |
| Bid | 65.26 x 400 |
| Ask | 65.33 x 200 |
| Day's range | 65.09 - 67.90 |
| 52-week range | 65.09 - 87.87 |
| Volume | |
| Avg. volume | 7,349,480 |
| Market cap | 81.39B |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | 14.50 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.08 (4.72%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- Zacks
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- Barrons.com
Gilead Beats Earnings Expectations After Rocky Quarter
The biotech reported a loss for the quarter of $1.32 per share, better than the FactSet consensus estimate of a loss of $1.49 per share.
- GuruFocus.com
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
Comprehensive Analysis of Gilead's First Quarter Financial Performance
© 2024 Yahoo. All rights reserved.